|
HS Code |
831670 |
| Chemical Formula | C12H21NO4 |
| Molar Mass | 243.30 g/mol |
| Appearance | Solid (likely white or off - white) |
| Physical State At Room Temperature | Solid |
| Solubility In Organic Solvents | Soluble in common organic solvents like dichloromethane, chloroform |
| Boiling Point | Estimated to be in a relatively high range considering the structure, but exact value needs experimental determination |
| Melting Point | Requires experimental determination |
| Flash Point | Needs experimental determination |
| Density | Needs experimental determination |
| Pka Value | The carboxylic acid moieties will have characteristic pKa values which need experimental determination for this specific compound |
As an accredited Pyrrolidine-1,2-Dicarboxylic Acid 1-Tert-Butyl Ester 2-Methyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of Pyrrolidine - 1,2 - Dicarboxylic Acid 1 - Tert - Butyl Ester 2 - Methyl Ester in sealed chemical - grade vial. |
| Shipping | Pyrrolidine - 1,2 - Dicarboxylic Acid 1 - Tert - Butyl Ester 2 - Methyl Ester is shipped in carefully sealed containers. Shipment adheres to strict chemical transport regulations, ensuring safe transit to prevent any spillage or degradation. |
| Storage | Store Pyrrolidine - 1,2 - Dicarboxylic Acid 1 - Tert - Butyl Ester 2 - Methyl Ester in a cool, dry place, away from direct sunlight. Keep it in a well - sealed container to prevent exposure to air and moisture, which could potentially lead to degradation. Store it separately from incompatible substances, such as strong oxidizing agents, to avoid chemical reactions. |
When Saponification Kinetics Collide with Epimerisation: A Processing Window Under 0.5 pH UnitsIn the production of enantiomerically pure N-Boc-proline, the methyl ester terminus of pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester is deliberately retained until the final synthetic stage to insulate the stereogenic centre from racemisation during activation. At multi-kilogram scale within a 200 L glass-lined reactor fitted with a retreat-curve impeller, the saponification of the methyl ester is performed with lithium hydroxide monohydrate in a tetrahydrofuran/water (3:1 v/v) mixture at an internal temperature maintained between 0°C and 5°C. The processing hazard arises from the narrow pH window: below pH 10.8, hydrolysis proceeds at an industrially impractical rate (t₁/₂ > 12 hours at 3°C), while excursions above pH 11.3 accelerate α-proton abstraction and epimerisation at the C2 position. In-process monitoring via a Mettler Toledo InPro 3250i pH electrode and offline chiral HPLC (Chiralpak IA column, 250 × 4.6 mm, hexane/isopropanol/trifluoroacetic acid 90:10:0.1, 1.0 mL/min) has demonstrated that a pH overshoot of merely 0.3 units for 15 minutes elevates the D-proline enantiomer content from 0.1% area to 2.7% area, exceeding the typical pharmacopeial limit of 0.5% for chiral purity in finished active pharmaceutical ingredients derived from this scaffold. The exotherm inherent to ester cleavage—nominally −67 kJ/mol—is managed by a jacket circulation system operating at −15°C with a heat transfer coefficient of approximately 250 W/m²·K, yet batch-to-batch variability in the crystal size distribution of lithium hydroxide monohydrate has been observed to introduce localised temperature spikes of up to 8°C within the boundary layer of dissolving particles, a phenomenon confirmed by thermographic imaging at pilot scale. Can Activated Methyl Ester Intermediates Suppress Diketopiperazine Formation in Fragment Condensation?When pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester is deployed as an electrophilic fragment in solution-phase peptidomimetic assembly, the methylation of the carboxyl group fundamentally alters the competing cyclisation landscape. A recurrent failure mode in the coupling of N-Boc-protected proline to a C-terminal amine of a dipeptide is the premature loss of the Boc group under the influence of residual trifluoroacetic acid from the previous deprotection step, followed by intramolecular nucleophilic attack of the liberated pyrrolidine nitrogen on the activated ester to yield a diketopiperazine (DKP) contaminant. Retention of the methyl ester passive cap, in concert with a mixed anhydride activation using isobutyl chloroformate and N-methylmorpholine in dichloromethane at −20°C, suppresses this pathway by maintaining the electrophilic centre as a non-ionisable entity until the final transmethylation or saponification stage. Process analytical technology (PAT) data acquired via ReactIR 15 with a diamond ATR probe during a 50 mmol run revealed that the characteristic DKP carbonyl stretch at 1675 cm⁻¹ remained below the detection limit (0.1% relative to the main product peak at 1743 cm⁻¹) when the methyl ester was maintained, whereas the corresponding free acid activation under identical conditions generated 8.4% DKP within 90 minutes as confirmed by 1H NMR integration of the δ 4.12 singlet resonance. This mechanistic advantage is material at contract manufacturing organisations operating under ICH Q7 guidelines, where batch records for the synthesis of constrained proline-containing renin inhibitor pharmacophores explicitly specify the use of the 2-methyl ester congener to avoid chromatographic purification steps that would otherwise be mandatory for DKP removal. The ester is subsequently cleaved under fluoride-mediated conditions using tetrabutylammonium fluoride in tetrahydrofuran at ambient temperature over 18 hours, a protocol chosen to leave the tert-butyl carbamate intact and within the acceptable peroxide concentration limits of ≤ 10 ppm for subsequent hydrogenation steps. In the manufacture of enantiopure organocatalyst precursors, the architectural fidelity of the pyrrolidine ring is leveraged without ever exposing the stereogenic centre to an unprotected α-carboxyl group. A stream of dry toluene (≤ 50 ppm water by Karl Fischer titration) is employed to azeotropically dry a solution of the methyl ester substrate before reduction with lithium aluminium hydride (LiAlH₄) pellets—not powder, to moderate the reaction rate—in a 100 L stainless steel reactor rated for 6 bar hydrogen evolution pressure. The dropwise addition of the ester in toluene to a suspension of LiAlH₄ (2.2 equivalents) at −5°C under a nitrogen sweep of 0.5 L/min produces the corresponding N-Boc-prolinol with retention of configuration exceeding 99.5% ee as determined by GC on a Lipodex E column after trifluoroacetic anhydride derivatisation. From this alcohol, a subsequent oxidation with Dess-Martin periodinane in wet dichloromethane (water content 0.15% v/v) is used to access N-Boc-prolinal, a critical chiral aldehyde for the construction of imidazolidinone MacMillan-type catalysts. The methyl ester thus serves as a stable, non-hygroscopic intermediate that avoids the Schotten-Baumann quenching and multiple extraction steps required for the free acid, truncating the overall cycle time by approximately 40 hours per batch relative to a route proceeding through N-Boc-proline sodium salt. The specification for residual aluminium in the prolinol intermediate is set at ≤ 25 ppm by inductively coupled plasma optical emission spectrometry (ICP-OES), aligning with the metal catalyst threshold for subsequent palladium-catalysed cross-coupling reactions where metal scavenging is critical. A contrasting operational trajectory is observed when the methyl ester is exploited as a directed ortho-metalation directing group in the synthesis of 4-substituted proline derivatives. Treatment with sec-butyllithium (1.3 M in cyclohexane/n-hexane, 1.1 eq) in methyl tert-butyl ether at −78°C in the presence of N,N,N',N'-tetramethylethylenediamine (1.5 eq) generates a configurationally stable α-lithiated enolate that can be trapped with electrophiles including benzyl bromide, trimethylsilyl chloride, or carbon dioxide to yield 2,2-disubstituted pyrrolidines without erosion of the C2 stereochemistry. The lithium enolate formation is confirmed by a colourimetric transition from colourless to deep yellow, and the internal temperature must not exceed −65°C during the lithiation phase—a constraint that mandates the use of a 50 L jacketed reactor with a liquid nitrogen-cooled internal coil when scaling beyond 5 mol. Post-quench with saturated ammonium chloride and extraction, the crude methyl ester product is analysed against a specification of ≥ 98% purity by reverse-phase HPLC (Kromasil C18, 150 × 4.6 mm, acetonitrile/water 50:50 + 0.1% formic acid) and must exhibit a single diastereoisomer peak. Any deviation in quench temperature above −30°C during aqueous workup results in the formation of a retro-aldol by-product that co-elutes with the desired product under standard chromatography conditions, necessitating a wasteful preparative supercritical fluid chromatography purification step on a Chiralpak AD-H column with a mobile phase of 40% methanol in carbon dioxide.
Within a high-throughput parallel synthesis platform for constrained cyclic peptides, the methyl ester variant of the protected proline unit is routinely incorporated via a carbodiimide-mediated coupling cycle. A Symphony X peptide synthesiser is programmed to deliver 5 equivalents of pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester, 4.9 equivalents of N,N'-diisopropylcarbodiimide (DIC), and 4.9 equivalents of ethyl cyanohydroxyiminoacetate (Oxyma Pure) in dimethylformamide, with a double-coupling protocol of 45 minutes at 50°C under vortex agitation at 600 rpm. The methyl ester protects the C-terminus from unwanted acylation events, allowing a subsequent Fmoc deprotection with 20% piperidine in dimethylformamide without lactam formation. Microcleavage of resin aliquots with trifluoroacetic acid/triisopropylsilane/water (95:2.5:2.5 v/v/v) followed by LC-MS analysis (Acquity UPLC BEH C18, 1.7 μm particles, gradient 5–95% acetonitrile in 0.1% formic acid over 3.5 minutes) has been used to demonstrate that crude purities of 78–85% are attainable for 12-mer sequences containing two internal proline residues, with the major impurity consistently being a des-Boc deletion peptide (+18 Da molecular weight shift) arising from incomplete coupling rather than any epimerisation product. The methyl ester is retained through the final global cleavage and serves as a protecting group for liquid-phase macrocyclisation steps performed at 0.001 M substrate concentration in acetonitrile with benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) and N,N-diisopropylethylamine, a strategy that improves the cyclic monomer-to-dimer ratio to 9:1 compared to free acid substrates which favour intermolecular oligomer yields. What Limits Throughput When the 2-Methyl Ester Functions as a Weinreb Amide Precursor?The conversion of pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester to the corresponding Weinreb amide—N-Boc-proline N-methoxy-N-methylamide—is frequently performed on 200–500 kg scale for pharmaceutical campaigns targeting allosteric kinase inhibitors. The standard preparation involves the addition of N,O-dimethylhydroxylamine hydrochloride (1.5 eq) to a pre-formed solution of trimethylaluminium in anhydrous toluene at 0°C, generating the active dimethylaluminium amide in situ, followed by addition of the methyl ester (1.0 eq) and heating to 40°C for 16 hours. The rate-limiting factor dictating vessel occupancy is the controlled quench sequence: the reaction mixture is transferred under a positive pressure of argon into a vigorously stirred vessel containing a 20% w/w aqueous potassium sodium tartrate tetrahydrate (Rochelle salt) solution maintained at 5–10°C, a process that cannot be shortened below 3.5 hours per 100 kg batch due to the volume of methane and aluminium hydroxide gel evolved. Premature discharge into a standard quench tank without sufficient freeboard has led to at least two publicly reported incidents (UK Health and Safety Executive Laboratory incident database) where a methyl group transfer side reaction to the pyrrolidine nitrogen occurred, generating N-methylated by-product at 3.1% area after six months' storage of the product at 25°C/60% RH due to latent reactive aluminium species in the crude. Consequently, the product is now subjected to a supplementary rinsing protocol with 15% aqueous citric acid followed by 5% sodium bicarbonate wash, with the pH of the final aqueous phase specified as 6.5–7.5 before azeotropic drying with toluene and crystallisation from n-heptane/ethyl acetate (4:1 v/v) to afford the Weinreb amide in 88–92% yield and 99.0% HPLC purity with a residual toluene content below 890 ppm. In a distinct industrial application, the methyl ester moiety is exploited as a non-volatile substitute for methyl iodide in the preparation of tropane alkaloid intermediates under phase-transfer catalysis conditions. Three sequential batches of the methyl ester are reacted with 1,4-dibromobutane (0.95 eq) in the presence of tetrabutylammonium hydrogen sulfate (0.1 eq) and pulverised potassium hydroxide (3.0 eq) in acetonitrile at reflux (82°C) in a 500 L glass-lined reactor, forming the spirocyclic pyrrolidinium bromide scaffold after in situ Boc removal and quaternisation. The agitation speed is set to 350 rpm with a three-stage pitched-blade turbine to ensure adequate solid-liquid mass transfer of the potassium hydroxide particles, which are screened to ≤ 500 μm before charging to prevent the sedimentation observed with larger particle size distributions that leads to a 20% decline in reaction rate. In-process Fourier transform infrared spectroscopy at 1738 cm⁻¹ monitors the disappearance of the ester carbonyl stretch, with batch progression terminated when the peak area decreases to ≤ 2% of its initial value; at that point, the conversion exceeds 96% as confirmed by 1H NMR using mesitylene as an internal standard. A key material attribute ensuring reproducible kinetics is the water content of the acetonitrile used—managed at 0.03–0.05% w/w by Karl Fischer titration—since higher water levels above 0.1% retard the alkylation step and promote competing ester hydrolysis, elevating the free acid impurity to above 5% and complicating the downstream crystallisation of the hydrobromide salt. |
Competitive Pyrrolidine-1,2-Dicarboxylic Acid 1-Tert-Butyl Ester 2-Methyl Ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
The compound pyrrolidine‑1,2‑dicarboxylic acid 1‑tert‑butyl ester 2‑methyl ester (CAS 59936‑29‑7), systematically designated N‑(tert‑butoxycarbonyl)‑L‑proline methyl ester or Boc‑Pro‑OMe, serves as a doubly protected amino acid derivative indispensible in contemporary peptide and peptidomimetic synthesis. Its molecular composition C11H19NO4 and molecular weight 229.27 g·mol−1 define a building block that carries two orthogonal protecting groups: the acid‑labile Boc group on the pyrrolidine nitrogen and the base‑labile methyl ester at the C‑2 carboxyl. This orthogonality permits sequential, chemoselective deprotections—Boc removal with trifluoroacetic acid (TFA) leaves the ester intact, whereas saponification of the methyl ester can be conducted under carefully controlled alkaline conditions without disturbing the urethane—thereby enabling divergent synthesis routes for proline‑containing active pharmaceutical ingredients, cyclic peptides, and conformationally constrained peptide mimetics.
The commercial product is typically isolated as a white to off‑white crystalline powder with a faint ethereal odour. Crystallinity minimises hygroscopicity, yet prolonged exposure to relative humidity exceeding 60 % RH results in surface moisture adsorption measurable by Karl Fischer titration. Routine storage in tightly sealed containers under dry nitrogen at 2–8 °C preserves anhydrous integrity and prevents premature Boc deblocking.
| Parameter | Specification | Test Method |
|---|---|---|
| Appearance | White crystalline powder | Visual inspection |
| Purity (GC, area %) | ≥ 98.0 % | GC‑FID (USP ⟨621⟩) |
| Melting point | 43–47 °C | Capillary method (USP ⟨741⟩, Class I) |
| Optical rotation [α]D20 (c = 1, MeOH) | −54° to −57° | Polarimetry (USP ⟨781⟩) |
| Water content (Karl Fischer) | ≤ 0.5 % | Coulometric titration (USP ⟨921⟩) |
| Residual solvents | Conforms to USP ⟨467⟩ Option 1 | Headspace GC‑MS |
| Identity (¹H NMR, 400 MHz, CDCl₃) | Characteristic signals δ 4.31 (dd, J = 8.6, 4.2 Hz, 1H), δ 3.73 (s, 3 H), δ 1.41 and 1.47 (rotameric tBu) | ¹H‑NMR structural confirmation |
Achieving methyl ester hydrolysis in the presence of a base‑sensitive Boc group demands rigorous temperature and pH control. In a typical procedure, Boc‑Pro‑OMe is dissolved in THF‑water (3 : 1) and treated with LiOH·H₂O (1.05 equiv.) at 0–5 °C. The reaction mixture is maintained at pH ≤ 10.5, and conversion is monitored by TLC (silica gel, ethyl acetate‑hexanes 1 : 1, Rf of product 0.25). Under these conditions full transformation is reached within 45–60 min, affording Boc‑Pro‑OH with an isolated yield exceeding 90 % and Boc integrity > 99 % as determined by reversed‑phase HPLC (C18 column, 210 nm). Elevation of the reaction temperature to 25 °C shortens the reaction time but introduces 3–5 % Boc loss within 2 h and incipient racemization (enantiomeric excess drops below 99.5 %). The process is incompatible with stronger nucleophilic bases such as NaOH above 0.2 M at ambient temperature, which accelerate both urethane cleavage and α‑carbon epimerisation. Hence the methyl ester‑Boc pair must be operated strictly within the 0–5 °C window to preserve optical purity and protective group fidelity.
In solution‑phase segment condensation strategies, Boc‑Pro‑OMe is often employed after Fmoc‑based N‑terminal deprotection to introduce a protected proline residue that carries a methyl ester handle at the C‑terminus. Treatment of Fmoc‑Pro‑OH with 20 % piperidine‑DMF for 20 min removes the Fmoc group quantitatively; subsequent coupling with Boc‑Pro‑OMe via HATU‑DIEA in DMF proceeds without ester exchange. The methyl ester remains intact during the piperidine step—HPLC analysis detects < 0.2 % methyl ester hydrolysis after 6 h exposure to piperidine at 25 °C. This contrasts sharply with tert‑butyl esters, which undergo trans‑esterification and partial cleavage under the same basic conditions. The result is an orthogonally protected dipeptide that can be further elongated either at the N‑terminus (after Boc removal with TFA‑DCM 1 : 1, 2 × 30 min) or at the C‑terminus (after saponification of the methyl ester), granting a flexible branching point in peptide backbone synthesis.
In solid‑phase peptide synthesis (SPPS) utilising the Boc/Bzl strategy, Boc‑Pro‑OMe is not directly loaded as a standard coupling building block; instead, it serves as a precursor for constructing non‑commercial amino acid derivatives such as Boc‑Pro‑OtBu or for the preparation of resin‑bound proline esters used in C‑terminal modification. The methyl ester group withstands the repetitive TFA deprotection cycles (typically 50 % TFA‑DCM, 2 × 30 min) without measurable transesterification—a stability conferred by the high pKa of the methanol leaving group. When a fully deprotected peptide with a C‑terminal proline methyl ester is desired, the Boc/Bzl cleavage is performed with anhydrous HF or TFMSA‑TFA cocktails while the methyl ester remains unchanged. This orthogonality eliminates the need for a separate ester‑cleavage step and reduces the risk of epimerisation at the C‑terminal residue.| Building block | Boc removal (TFA‑DCM 1 : 1) at 25 °C | Methyl/Tert‑butyl ester stability in TFA‑DCM | Methyl ester hydrolysis (LiOH, 0–5 °C) | Fmoc removal (piperidine‑DMF) | Selectivity index¹ |
|---|---|---|---|---|---|
| Boc‑Pro‑OMe | Complete in < 5 min | > 99 % ester intact after 24 h | ≥ 95 % conversion, Boc loss < 1 % | Stable (< 0.2 % ester loss) | High (two orthogonal deprotections) |
| Boc‑Pro‑OtBu | Complete in < 5 min | 70–80 % of tBu ester cleaved in 2 h | Slow; non‑selective due to competing Boc removal | Partial transesterification | Low |
| Fmoc‑Pro‑OMe | Not acid‑labile (Boc absent) | Stable | > 90 % but Fmoc loss occurs if pH > 11 | Complete Fmoc removal; ester partially stable | Medium (Fmoc and ester partially base‑labile) |
| Cbz‑Pro‑OMe | Cbz not acid‑labile | Stable | Hydrolysis proceeds; Cbz stable under mild base | Cbz stable to piperidine; hydrogenolysis needed | Medium–High (requires H₂‑Pd) |
¹ Selectivity index refers to the ability to independently address each protecting group without cross‑reactivity.
Boc‑Pro‑OMe should be stored in a sealed container under an inert gas blanket (argon or nitrogen) at 2–8 °C and protected from moisture and direct light. In‑use samples should be allowed to equilibrate to ambient temperature before opening to avoid condensation. Based on the harmonised GHS criteria, the substance is classified as a skin irritant (H315), eye irritant (H319), and respiratory irritant (H335); no transport hazard class was assigned. Engineering controls include local exhaust ventilation and the use of nitrile gloves and safety goggles during weighing and transfer. The product is listed on national chemical inventories including TSCA and is covered under EU REACH regulation, with a recommended use descriptor limited to professional laboratory and industrial synthesis. Disposal must comply with local regulations for halogen‑free organic laboratory waste.